Form 8-K RESMED INC For: Oct 24
ResMed Inc. (RMD)
Last resmed inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.resmed.com/investor-relations/default.aspx
Company Research
Source: SEC EDGAR
Impact Snapshot
Event Time:
RMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RMD alerts
High impacting ResMed Inc. news events
Weekly update
A roundup of the hottest topics
RMD
News
- MDT Stock Gains From FDA Approval for Its InPen App [Yahoo! Finance]Yahoo! Finance
- ResMed expands Singapore operations to address obstructive sleep conditions [CNBC]CNBC
- This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar [Yahoo! Finance]Yahoo! Finance
- Rebalance Health Demonstrates Significant Sleep Benefits in New Blind Placebo Study [Yahoo! Finance]Yahoo! Finance
- ResMed's (NYSE:RMD) earnings growth rate lags the 11% CAGR delivered to shareholders [Yahoo! Finance]Yahoo! Finance
RMD
Earnings
- 10/24/24 - Beat
RMD
Sec Filings
- 11/22/24 - Form 144
- 11/22/24 - Form 4
- 11/22/24 - Form 4
- RMD's page on the SEC website